Contents
The Optimum Labs fraud case involved more than $4.7 million in false claims to MassHealth for sober-home urine drug tests, according to Massachusetts’ Attorney General. In the criminal-case announcement, the office described unnecessary tests, tests never performed or properly authorized, and tests tied to illegal kickbacks. For someone inside a laboratory or sober home, the state’s account concerns everyday work: who ordered the test, what actually ran, and why the specimen went to that laboratory.
Optimum Labs was a clinical laboratory based in New Bedford, Massachusetts. The Attorney General’s Office announced guilty pleas and admissions in the criminal case involving the laboratory and its owner on July 28, 2025. The charges concerned two separate MassHealth fraud and kickback schemes.
The state’s criminal case concerned urine drug tests that MassHealth did not cover, including tests the state said were medically unnecessary, unperformed, improperly authorized or connected to kickbacks.
An unperformed-test allegation concerns the work behind the bill. An authorization allegation concerns who requested that work. Medical necessity concerns the reason for testing the patient. A kickback allegation follows the money that brought the testing business to the laboratory. Treating all of those as a billing problem misses the decisions that come before a claim exists.
That distinction matters to an employee who sees only part of the process. Someone working with specimens may know what the laboratory received and tested. Someone handling orders may know where the requests originated. A biller may see what the payer was told. The state’s Optimum account puts those separate views of the same urine test at the center of the case.
Toxicology tests are unnecessary when their selection or repetition lacks a clinical reason tied to the patient’s care. In the Optimum criminal case, the state identified medically unnecessary sober-home testing among the claims that were not payable by MassHealth. The broader clinical literature explains why the patient’s circumstances matter.
The Journal of Family Practice’s 2021 review, Urine Drug Screening: A Guide to Monitoring Tx With Controlled Substances, recommends testing frequency based on risk. In its discussion of addiction treatment, it says routine testing at every visit is often unnecessary for stable patients.
The review also identifies the financial pressure in the opposite direction: practices with a financial interest may use large, expensive panels, test too frequently or send positive tests for unnecessary additional analysis. The treatment question is what information the patient needs next. The business incentive can be to keep the same volume of tests coming.
An independent laboratory can hold the test order and submit the claim while the clinician holds the medical record explaining why the test was needed. That division of work makes the ordering relationship central to understanding laboratory fraud.
Medicare’s laboratory documentation rules make the division explicit: the ordering clinician maintains the medical-necessity documentation, while the billing entity maintains what it received and evidence that its claim accurately reflects that information. The industry point is that the clinical justification and the bill can sit in different organizations.
The requisition connects them. In its 1998 clinical-laboratory guidance, the HHS Office of Inspector General said the form should support an independent medical-necessity decision for each test the laboratory will bill. It also discouraged standing orders and called for monitoring and renewal.
For recurring sober-home testing, that gives the order history practical importance. We look at who selected the tests, how the request reached the laboratory and whether the clinical reason continued to support the recurring work. An order’s creation, its renewal and the later claims can tell different parts of the story.
Yes. Government laboratory cases have alleged payments to doctors in exchange for test referrals. The Health Diagnostic Laboratory and Singulex settlements resolved allegations that the laboratories paid physicians processing and handling fees to induce blood-testing referrals.
The value can also come through supplies. The HHS Office of Inspector General’s 2014 Special Fraud Alert on laboratory payments identified free or below-market point-of-care urine cups as a concern when tied to referrals. A product used in everyday patient care can also be something of value to the business receiving it.
Optimum’s criminal case also concerned tests resulting from illegal kickback arrangements, according to the Attorney General’s announcement. The physician payments in the civil settlements above show one referral pattern. For the Optimum case, the question is what brought the specimens to the laboratory and who benefited from that business.
For an insider, the revealing documents may be in the sales or accounting files as well as the testing records. A processing-fee label describes what an invoice calls a payment. The referral arrangement explains what the payment bought.
A sober home’s interest in monitoring a resident and a clinician’s reason for ordering diagnostic testing answer different questions. GENCO Lab settled allegations of billing for urine tests used solely to monitor sober-home residents, a purpose the government said was prohibited. The Optimum criminal announcement separately identifies unnecessary and improperly authorized sober-home tests.
The strongest account connects the order, the work performed, the claim and the referral relationship. A healthcare employee who recognizes an unnecessary-testing routine may understand a decision that is invisible in a billing total. A laboratory employee may know whether the service on the claim matches the work actually done. A person handling referral payments may know why specimens kept arriving from a particular source.
We work with that firsthand knowledge to identify the decisions behind the documents. Where the concern is recurring testing, the patient-specific reason and order history matter. Where the concern is unperformed work, the laboratory’s testing records matter. Where the concern is purchased referrals, the payment arrangement matters. Those connections give a health care whistleblower case its substance.
A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.
If you know who generated the sober-home orders, what the laboratory actually tested or what brought in the referrals, talk with our whistleblower experts about the conduct you saw. We build your strongest laboratory fraud whistleblower case around those connections, bring in laboratory fraud whistleblower lawyers who understand testing and referral arrangements, and stay beside you through the pursuit of a recovery.